Extracellular matrix change in patients with various forms of atrial fibrillation

Purpose: We studied the change in serum collagen markers in patients with various forms of atrial fibrillation (AF) Methods: Collagen type C-terminal propeptide (CTPK-I), C-terminal telopeptide of type I collagen (CTTK-I), matrix metalloproteinase I, and tissue inhibitors of matrix metalloproteinase...

Full description

Saved in:
Bibliographic Details
Main Authors: A. V. Goryachiy (Author), A. I. Gozhenko (Author), E. M. Levchenko (Author), V. V. Goriachyi (Author), M. A. Kuznetsova (Author), M. I. Arapu (Author)
Format: Book
Published: Kazimierz Wielki University, 2017-06-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Purpose: We studied the change in serum collagen markers in patients with various forms of atrial fibrillation (AF) Methods: Collagen type C-terminal propeptide (CTPK-I), C-terminal telopeptide of type I collagen (CTTK-I), matrix metalloproteinase I, and tissue inhibitors of matrix metalloproteinase I were used as markers for collagen synthesis. The study group comprised - 70 people, control - 20. Results: The level of CTCP-I and CTTP-I in patients with AF was significantly higher in comparison with the control group (91 +27 ng / ml, 67 + 11 ng / ml, p
Item Description:2391-8306